UniTTEC Co., Ltd. (000925.SZ) and its subsidiary consortium won the bid for the 1.57 billion yuan Chengdu Metro Line 2 signal system onboard subsystem construction project.
Zhonghe Technology (000925.SZ) announcement, the company recently received a tender from Chengdu Rail Transit Group Co., Ltd...
Announcement from UniTTEC Co., Ltd. (000925.SZ): The company recently received a "Notice of Bid Winning" (Number: Railway Group Middle Character [2024] 029) from Chengdu Rail Transit Group Co., Ltd. (the bidding unit), confirming that the company and its controlling subsidiary, Chengdu Zhonghe Intelligent Rail Transit Technology Co., Ltd., jointly won the bid for the "Chengdu Metro Line 2 Signal System Onboard Subsystem Repair Project" with a contract amount of 157 million RMB.
Project Overview: The project involves replacing the remaining signal onboard subsystem equipment on 60 trains (201-260) of Line 2, including onboard controllers, racks, cages, speed and positioning devices, driver displays, beacon readers, positioning antennas, and cables. The scope of work includes, but is not limited to, equipment supply, removal of existing equipment and installation of new equipment, equipment and software debugging, signal system testing, train testing, integrated testing, interface testing, and other relevant work as required by the bidding unit.
Related Articles

LIFETECH SCI (01302): G-BranchTM thoracoabdominal aortic stent graft system has been officially registered and approved by the National Medical Products Administration.

US Stock Market Move | Forge Global (FRGE.US) surged 66% in pre-market trading, receiving a $660 million investment from Charles Schwab (SCHW.US) for acquisition.

BeiGene's third quarter revenue exceeded the hundred billion mark, and the full-year performance guidance has been adjusted upward.
LIFETECH SCI (01302): G-BranchTM thoracoabdominal aortic stent graft system has been officially registered and approved by the National Medical Products Administration.

US Stock Market Move | Forge Global (FRGE.US) surged 66% in pre-market trading, receiving a $660 million investment from Charles Schwab (SCHW.US) for acquisition.

BeiGene's third quarter revenue exceeded the hundred billion mark, and the full-year performance guidance has been adjusted upward.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


